Immutep Limited PRRUF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.94M | 4.83M | 1.98M | 1.97M | 604.40K |
| Total Other Revenue | -- | -- | -- | -- | 3.00K |
| Total Revenue | 4.94M | 4.83M | 1.98M | 1.97M | 607.30K |
| Cost of Revenue | 16.09M | 15.73M | 15.30M | 15.25M | 11.56M |
| Gross Profit | -11.15M | -10.90M | -13.32M | -13.28M | -10.95M |
| SG&A Expenses | 1.47M | 1.44M | 1.78M | 1.78M | 1.41M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.56M | 17.17M | 17.08M | 17.03M | 12.97M |
| Operating Income | -12.63M | -12.34M | -15.10M | -15.06M | -12.36M |
| Income Before Tax | -12.23M | -11.95M | -14.72M | -14.68M | -12.51M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.23M | -11.95M | -14.72M | -14.68M | -12.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.23M | -11.95M | -14.72M | -14.68M | -12.51M |
| EBIT | -12.63M | -12.34M | -15.10M | -15.06M | -12.36M |
| EBITDA | -12.25M | -11.98M | -14.73M | -14.69M | -12.01M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.47B | 1.47B | 1.47B | 1.47B | 1.46B |
| Average Diluted Shares Outstanding | 1.47B | 1.47B | 1.47B | 1.47B | 1.46B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |